Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment.
Marchand K, Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Schechter MT.
Harm Reduct J. 2012 Jan 25;9(1):8.
Related citations
Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.
Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT.
BMC Health Serv Res. 2011 Jul 26;11:174.
History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
Oviedo-Joekes E, Marchand K, Guh D, Marsh DC, Brissette S, Krausz M, Anis A, Schechter MT.
Addict Behav. 2011 Jan-Feb;36(1-2):55-60. Epub 2010 Sep 19.
Diacetylmorphine versus methadone for the treatment of opioid addiction.
Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT.
N Engl J Med. 2009 Aug 20;361(8):777-86.
Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
Oviedo-Joekes E, Nosyk B, Marsh DC, Guh D, Brissette S, Gartry C, Krausz M, Anis A, Schechter MT.
Clin Trials. 2009 Jun;6(3):261-71.
Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, Anis A, Schechter MT.
J Subst Abuse Treat. 2010 Jun;38(4):408-11. Epub 2010 Mar 31.
The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.
Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT.
J Urban Health. 2008 Nov;85(6):812-25. Epub 2008 Aug 29.
Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.
Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT.
Can J Public Health. 2010 May-Jun;101(3):210-2.
NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America.
Gartry CC, Oviedo-Joekes E, Laliberté N, Schechter MT.
Harm Reduct J. 2009 Jan 21;6:2.
Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, Stewart D, Welch S.
Addiction. 2000 Nov;95(11):1631-45.
Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency.
Oviedo-Joekes E, Marsh DC, Guh D, Brissette S, Schechter MT.
J Opioid Manag. 2011 Sep-Oct;7(5):371-6.
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM.
JAMA. 2000 Mar 8;283(10):1303-10.
The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.
Nosyk B, Geller J, Guh DP, Oviedo-Joekes E, Brissette S, Marsh DC, Schechter MT, Anis AH.
Drug Alcohol Depend. 2010 Sep 1;111(1-2):161-5. Epub 2010 May 26.
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS.
Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. Review.
Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.
Lintzeris N, Strang J, Metrebian N, Byford S, Hallam C, Lee S, Zador D; RIOTT Group.
Harm Reduct J. 2006 Sep 27;3:28.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.
Arch Gen Psychiatry. 1999 Sep;56(9):812-20.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Methadone at tapered doses for the management of opioid withdrawal.
Amato L, Davoli M, Ferri M, Ali R.
Cochrane Database Syst Rev. 2003;(3):CD003409. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003409.
Cochrane Database Syst Rev. 2002;(2):CD003409. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD003409.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on